baber/WOPTO huggingface dataset:
Patent NZ-554834-A (NZ)
Title: Fixing and release systems
Inventor: RUDDUCK DICKORY
Filed: 1999-03-18
Abstract: A connecting means adapted to releasably fix a first element and a second element, the connecting means comprising a locking means movable by remote activation means between a locked position in which the first element is locked to the second element either by rotation of the locking means or by blocking of a movable member, and an unlocked position in which the first element is released from the second element, wherein there is no permanent material connection between the connecting means and the remote activation means, and wherein the connecting means comprises receiving means for receiving a signal from the remote activation means to fix or release the first and second elements and for activating movement of the locking means to the locked or unlocked position in accordance with the signal.
Patent NZ-556082-A (NZ)
Title: Controlled release of biological entities
Inventor: FINNIE KIM SUZANNE
IPC: A61K9/22
Filed: 2005-12-20
Abstract: Disclosed is a process for releasably encapsulating a biological entity comprising: a) combining a solution of a surfactant in a non-polar solvent with a precursor material and the biological entity to form an emulsion comprising a polar phase dispersed in a non-polar phase, said polar phase comprising the biological entity; and b) aggregating primary particles in the emulsion to form ceramic particles comprising the biological entity from the polar phase.
Patent NZ-560790-A (NZ)
Title: (1,5-diphenyl-1H-pyrazol-3-yl)oxadiazole derivatives, preparation method thereof and use of same in therapeutics
Inventor: BARTH FRANCIS
IPC: A61P1/00
Filed: 2006-02-17
Abstract: Disclosed is a compound of formula (I), wherein R1 represents a heterocyclic radical chosen from (Ia), (Ib) or (Ic) and the other substituents are as defined in the specification, and processes for their preparation . The compounds possess antagonist properties for CB1 and are useful in the treatment of diseases involving CB1 cannabinoid receptors, e.g. psychiatric disorders, disorders of appetite and alcohol or nicotine dependence.
Patent NZ-563224-A (NZ)
Title: Substituted acrylamide derivative and pharmaceutical composition comprising the same
Inventor: AOKI KAZUMASA
IPC: A61K31/166
Filed: 2006-05-11
Abstract: Disclosed are substituted acrylamide compounds of Formula (I') or a pharmacologically acceptable salt thereof, wherein the substituents are as defined in the specification, and the use of substituted acrylamide compounds of Formula (I) or a pharmacologically acceptable salt and compounds of Formula (I') for treating suppression of bone resorption.
Patent NZ-568450-A (NZ)
Title: Tube heat sheild reflector
Inventor: HARVEY GLENN RAYMOND
IPC: F24S10/70
Filed: 2009-07-31
Abstract: An assembly to shield a solar tube is disclosed. The assembly includes: (a) a shield having a cross section in the form of an arc cross section, and at least one recessed groove shaped to at least partially cover a solar tube; (b) a first clip located at one distil end of the shield and at least one further clip located sufficiently far from the first clip so that the clips retain the shield in a concentric position relative to the tube; and, (c) a shield rotating and fixing mechanism which communicates with the first clip to rotate the shield from a sun shading closed position via intermediate positions and to an open position where no shading occurs. The groove or grooves of the shield are received and retained by at least one corresponding receiving aperture or apertures in the clip or clips.
Patent NZ-568587-A (NZ)
Title: A lock with an improved snib mechanism
Inventor: NEWMAN DONALD JOHN
IPC: E05B63/08
Filed: 2006-11-20
Abstract: A lock has a lock tongue which is moveable between a latching position and a free position, a handle to move the lock tongue, a locking member that is moveable between a locking position to lock the lock tongue and an unlocking position, and an actuator that is movable by the handle between a first position and a second position. The actuator is operatively associated with the locking member so that movement of the actuator into the second position moves the locking member into the locking position.
Patent NZ-568668-A (NZ)
Title: Composite cable of carbon fibre bundle and surrounding conductor cable spiral wound and reversed in direction
Inventor: TONELLO GINO
IPC: H01R4/62
Filed: 2006-10-31
Abstract: A method for interconnecting a first electric cable (1), constituted by a carbon fibre bundle (2) enveloped in a first insulating sheath (3), with a second cable (4) constituted by a metallic conductor (5) enveloped in a second insulating sheath (6); the method provides for the removal of a first portion of the first sheath (3) that covers a first end (7) of the carbon fibre bundle, and the removal of a second portion of the second sheath (6) that covers a second end (8) of the metallic conductor (5), for an extension greater than that of the first portion. The method then provides for the spiral-like winding of the second end (8) of the metallic conductor (5), starting from the first end (7) of the first cable (1), until such metallic conductor (5) affects the first sheath (3), and then the change of direction of advancement of the spiral defined by such second end (8), to provide at least one loop (9) that covers the first sheath (3). The method then provides for the spiral-like winding of the metallic conductor (5) in a direction of the first end (7) of the bundle (2) and the mutual alignment of the first and second cables (2,4), and then the addition of at least one layer (not shown) of tin or other conductor or covering element to totally cover the second end (8) of the metallic conductor (5).
Patent NZ-570633-A (NZ)
Title: Flurophenoxy-piperazine derivatives
Inventor: SUN CONNIE L
IPC: C07D295/088
Filed: 2007-01-23
Abstract: Disclosed are flurophenoxy-piperazine derivatives as represented by the general formula (I), wherein R1 represents a phenyl group that is substituted by one or two fluorine atoms; A1 represents (CH2)m or (CH2)m-1C(=O); m is 2, 3, 4 or 5; A2 represents (CH2)n or C(=O)(CH2)n-1; n is 2, 3, 4 or 5; and R2 represents a phenyl group that is substituted by one, two or three substituents selected independently from alkylenedioxy, hydroxyl, cyano, cycloalkyl, haloalkyl, alkoxy, alkoxyalkoxy, hydroxyalkoxy, alkylsulfanyl, alkylsulfonyl, haloalkoxy or haloalkylsulfonyl; or a pharmaceutically acceptable salt thereof. Further disclosed is a pharmaceutical composition, which comprises a compound as defined above, and a pharmaceutically acceptable diluent or carrier for treating a neurological disorder or psychiatric disorder that has been linked to sigma receptors in a patient, and particularly for the treatment of conditions such as cerebral ischemia; spinal cord trauma; head trauma; multiple sclerosis, Alzheimer's Disease; Huntington's Chorea; amyotrophic lateral sclerosis; AIDS-induced dementia; muscular spasms; convulsions; drug tolerance, withdrawal, and cessation; ocular damage and retinopathy; cognitive disorders; idiopathic and drug-induced Parkinson's Disease; pain; tardive dyskinesia, schizophrenia, anxiety and related disorders; depression; bipolar disorders; psychosis; or obsessive compulsive disorders.
Patent NZ-572665-A (NZ)
Title: Transaction system supporting dynamic currency conversion
Inventor: LING JAMES
IPC: G06Q50/00
Filed: 2007-05-15
Abstract: A method of performing a transaction of funds in a card payment system using a payment card and the apparatus for use in a payment system for performing a dynamic currency conversion transaction using a payment card are disclosed. The method includes providing the option to perform the transaction using dynamic currency conversion. The apparatus comprises a transaction terminal including a user interface for indicating that dynamic currency conversion is required and for indicating a currency in which the transaction is to be processed to perform the dynamic currency conversion, an interface for receiving an account identifier of an account and a communication interface for communicating with a network. The account identifier is sourced from the payment card and the transaction terminal receives an account identifier from the interface for receiving an account identifier, and determines from the account identifier whether the payment card was issued by a local card issuer and, if so causing the transaction to be performed in a default currency. If the payment card was not issued by a local card issuer, the transaction terminal prompts for the input of a nominated currency, and receives a nominated currency in which the transaction is to be processed from the user interface. Then the transaction terminal a) at least one of: i) compares the account identifier with a listing of account identifiers maintained in memory and determines from the listing whether the transaction is eligible for dynamic currency conversion and ii) using the communication interface transmits particulars of the transaction including the nominated currency and receives a communication reporting whether the transaction is eligible for dynamic currency conversion; b) if the transaction is eligible for dynamic currency conversion and an input to the user interface indicates that dynamic currency conversion is required, initiates processing of the transaction in the nominated currency; ) if the transaction is not eligible for dynamic currency conversion or if an input to the user interface indicates that dynamic currency conversion is not required, initiates processing of the transaction in the default currency.
Patent NZ-576674-A (NZ)
Title: Stabilised biodiesel fuel compositions
Inventor: LI NATALIE R
IPC: C10L1/14
Filed: 2007-11-19
Abstract: A biodiesel fuel composition stabilized against the deleterious effects of heat, light, oxygen and metals, which composition comprises a biodiesel fuel comprising C1-C5alkyl esters of a mixture of saturated and unsaturated straight chain fatty acids of from 12 to 22 carbon atoms and an effective stabilizing amount of a combination of i) sterically hindered phenolic antioxidants including at least two of 2,6-ditert-butylphenol, 3,5-di-tert-butyl-4-hydroxyhydrocinnamic acid methyl ester and tetrakis-(3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionyloxymethyl)methane and ii) one or more compounds selected from the group consisting of triazole metal deactivators of formula (I) and (IV), wherein R1 and R2 are the same or different and are C1-C20alkyl; and R10 is hydrogen or methyl, R11 and R12 are the same or different and are C1-C20alkyl.
Patent NZ-576908-A (NZ)
Title: Spinach Line SMB66-1100M
Inventor: BAERENDS BERNARDUS
IPC: A01H5/12
Filed: 2009-05-12
Abstract: Disclosed is a seed of spinach line 5MB66-1100M a sample of seed of said line having been deposited under ATCC Accession Number PTA-9185.
Patent NZ-577576-A (NZ)
Title: Alarm device
Inventor: OOI MICHAEL
IPC: G08B17/113
Filed: 2009-06-10
Abstract: There is disclosed an alarm device (10) comprising a base (12) mountable to a wall or ceiling and a body (18). The body comprises a housing within which the operational components of the device are contained. The operational components include at least a sensor device and an alarm. The body is detachably mounted to the base by way of a lateral sliding action.
Patent NZ-579641-A (NZ)
Title: Initiation of explosives materials with a laser delivered by a fibre optic
Inventor: GOODRIDGE RICHARD JOHN
IPC: F42B3/10
Filed: 2008-03-14
Abstract: A blasting system is disclosed which comprises a bulk explosive (7), a confined explosive (2) and a fiber optic (4) adapted to deliver laser light to the confined explosive (2). The confined explosive (2) is provided relative to the bulk explosive (7) to cause initiation of the bulk explosive. A portion of the confined explosive (2) and a portion of the bulk explosive (7) are either in direct contact or a membrane is provided directly between. Where a membrane is provided the intended operative relationship between the confined explosive (2) and the bulk explosive (3) is retained.
Patent NZ-588558-A (NZ)
Title: Steroid nebuliser formulation comprising beclomethasone
Inventor: MCAFFER IAN GARDNER CAMERON
IPC: A61K9/12
Filed: 2009-04-16
Abstract: Disclosed is a nebuliser formulation, comprising crystallized beclomethasone hydrate particles of size 0.5 - 10 microns. The particles are obtained by forming a solution of beclomethasone in a solvent, forming droplets of the solution by generating an aerosol from this solution, forming a dispersion of the droplets in water and applying ultrasound to the droplets so as to initiate or effect crystallization of the beclomethasone.
Patent NZ-591184-A (NZ)
Title: Method of cleaning food and beverage manufacturing and handling equipmemt
Inventor: AHMED FAHIM U
IPC: B08B3/04
Filed: 2009-07-16
Abstract: Disclosed herein is a method of cleaning soiled food or beverage manufacturing and handling equipment including: · A cleaning step in which the surfaces of said equipment are contacted with a volume of a cleaning solution including an acidic detergent composition including a fatty alkyl-1,3 diaminopropane or salt thereof having the general formula R-NHCH2CH2CH2NH2, wherein R is a C4-C22 alkyl group, wherein said volume of cleaing solution is circulated through said equipment for a period of time to effect a reduction of the soils on said equipment surfaces; · A post rinsing step in which a volume of a rinse solution is circulated through said equipment contacting said equipment surfaces thereby removing residues of said detergent composition remaining on said equipment; and · A pre-rinse step in which a volume of pre-rinse fluid is circulated through said equipment prior to said cleaning step wherein the volume of said pre-rinse fluid used is less than 50% of the volume of cleaning solution used in said cleaning step.
Patent NZ-591943-A (NZ)
Title: Anti-tgf-beta receptor ii antibodies
Inventor: WU YAN
IPC: A61K39/395
Filed: 2009-10-29
Abstract: Disclosed are antibodies against human transforming growth factor beta receptor II (TGFâRII), pharmaceutical compositions comprising antibodies and methods of using the antibodies, alone or in combination, for example, for treating cancer and fibrosis.
Patent NZ-598614-A (NZ)
Title: Pyrimidine derivatives as protein tyrosine kinase 2 inhibitors
Inventor: SAPOUNTZIS IOANNIS
IPC: A61K31/506
Filed: 2010-10-01
Abstract: ABSTRACT - 598614 The disclosure relates to substituted pyrimidine derivatives of general formulae (1a) and (1b), wherein the variables R1 to R7, A, Q, m, n, p, q and r are defined as in the specification. These compounds are focal adhesion kinase (FAK/PTK2) inhibitors and thus suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, wherein the medicaments containing these compounds are useful for treating cancer (particularly prostate cancer, ovarian cancer, pancreatic cancer and bronchial cancer), infections, inflammations and autoimmune diseases.
Patent NZ-598659-A (NZ)
Title: Automated radiosynthesis
Inventor: WOODCRAFT JOHN
IPC: C07D487/04
Filed: 2010-10-08
Abstract: 598659 The present disclosure provides a method to obtain radiofluorinated ortho-[18F]flumazenil derivatives of formula I wherein R1 is hydrogen and R2 is 18F, from a precursor of formula Ia wherein R11 is hydrogen ad R12 is a leaving group such as nitro, trialkylammonium or an iodonium. Such compounds are useful for in vivo imaging GABAA receptors. A further aspect disclosed is a cassette suitable for carrying out the automated method of synthesis of the invention. Novel precursor compounds useful in the method of the invention are also provided, as are a number of novel compounds obtained by the method disclosed, such as the eythyl-, isopropyl- and tert-butyl- ortho-[18F]flumazenil derivatives.
Patent NZ-600487-A (NZ)
Title: Method and apparatus for preparing pulverized coal used to produce synthesis gas
Inventor: MARTIN WILLIAM N
IPC: B02C21/00
Filed: 2008-04-02
Abstract: 600487 Disclosed is a method for preparing coal for use in producing synthesis gas for use in gas turbines comprising the steps of: grinding coal in a pulveriser to produce pulverized coal; combusting synthesis gas (12) with air (14) in a gas turbine (16) to produce hot turbine exhaust gas (18) at a temperature of 650F-700F; conveying a first portion (24) of the hot turbine exhaust gas (18) to the coal pulveriser (60) to dry and convey the pulverized coal from the pulveriser (60) to a coal/gas separation device; conveying a second portion (22) of the hot turbine exhaust gas (18) through a waste heat recovery boiler (40) to produce cooled turbine exhaust gas (26, 28) at a temperature of about 300F or less; and mixing the first portion of the turbine exhaust gas (24) and the cooled turbine exhaust (26) together and then conveying the mixture to the coal pulveriser (60).
Patent NZ-614875-A (NZ)
Title: Sizing compositions
Inventor: EHRHARDT SUSAN M
IPC: D21H21/16
Filed: 2012-03-30
Abstract: Disclosed is an aqueous paper sizing composition comprising a hydrophobic paper sizing agent homogenised with an aqueous solution of a hydrophobically modified poly(aminoamide) having a pH below 4.0; wherein the hydrophobic poly(aminoamide) is a water soluble alkyl glycidyl ether modified poly(aminoamide); and wherein the viscosity of the composition does not exceed about 400 cps over 4 weeks storage at 32°C. The hydrophobic paper sizing agent may be selected from the group consisting of alkenyl succinic anhydride (ASA), alkyl ketene dimer (AKD), ketene dimers, ketene multimers, organic epoxides containing from about 12 to 22 carbon atoms, acyl halides containing from about 12 to 22 carbon atoms, fatty acid anhydrides from fatty acids containing from about 12 to 22 carbon atoms, organic isocyanates containing from about 12 to 22 carbon atoms, alkenyl succinic anhydride, an alkyl ketene dimer, unmodified rosin, fortified rosin, rosin ester, hydrogenated rosin, extended rosin, wax, hydrocarbon resins and mixtures thereof. Also disclosed is a method of sizing paper comprising: a) providing an aqueous solution of a water soluble alkyl glycidyl ether modified poly(aminoamide) having a pH below 4.0, b) mixing an unemulsified hydrophobic sizing agent with the alkyl glycidyl ether modified poly(aminoamide) solution to form a mixture, c) homogenising the mixture to form a stable oil-in-water emulsion, wherein the viscosity of the emulsion does not exceed about 400 cps over 4 weeks storage at 32ºC, and d) applying the emulsified hydrophobic sizing agent to wood pulp.
Patent NZ-615992-A (NZ)
Title: Automated gravimetric screening platform system and method
Inventor: GOLGOTIU KIRSTI A
IPC: A01G27/00
Filed: 2012-04-11
Abstract: An automated gravimetric screening system (10) and method controls soil moisture in a plurality of potted plants to perform water deficit experiments in a greenhouse using a stationary support platform (12) and pot design that maintains the plants in a static location during the testing. By weighing and re-watering the pots from beneath the platform, the present system and method permits an upper gantry (22) to capture high resolution images, temperature data, or other sensor data to quantify the plant stress level or plant canopy characteristics during the experiment.
Patent NZ-616637-A (NZ)
Title: Preparation of high-purity gadobutrol
Inventor: PLATZEK JOHANNES
IPC: C07F5/00
Filed: 2012-04-17
Abstract: Disclosed herein is a process for producing high-purity gadobutrol, a gadolinium-containing MR contrast agent, in a purity (according to HPLC) of more than 99.7or 99.8 or 99.9% and the use for preparing a pharmaceutical formulation for parenteral administration. The process is carried out using specifically controlled crystallization conditions.
Patent NZ-623346-A (NZ)
Title: Anti-htra1 antibodies and methods of use
Inventor: WU YAN
IPC: C07K16/00
Filed: 2012-10-12
Abstract: Discloses Anti-HtrA1 antibodies binding to an epitope including N224, K248, or both of HtrA1. Also discloses associated methods of treating age-related macular degeneration, geographic atrophy, diabetic retinopathy, retinopathy of prematurity, and polypoidal choroidal vasculopathy.
Patent NZ-626348-A (NZ)
Title: Surface lure
Inventor: ULYANOV SERGIY VLADLENOVYCH
IPC: A01K85/16
Filed: 2012-03-19
Abstract: The surface lure comprises a longitudinally elongated convex curved plate 1, metal load 2, device for fixing a fishing line in the front portion of the lure, and at least one hook 10 at the tail portion of the lure. The metal load 2 is longitudinally elongated, flattened in the vertical plane, with the upper edge being narrowed and rectilinear or concave in form in the middle. Two rods 3 projecting upwardly in the vertical plane above the upper edge of the load 2, and are threaded through holes in the plate 1 which is located on the top of the load 2. The side portions of the longitudinally elongated and curved plate 1 are symmetrically bent downward relative to its longitudinal axis. The plate 1 is attached to the load such that it can rotate about its longitudinal axis in both directions. At least one hook at the tail portion of the lure is attached to the load.
Patent NZ-628758-A (NZ)
Title: Processing materials with ion beams
Inventor: MEDOFF MARSHALL
IPC: C10G19/00
Filed: 2009-06-17
Abstract: The disclosure relates to a method of changing a molecular structure of a cellulosic or lignocellulosic biomass material, wherein the method comprises the steps of: producing an ion beam having a distribution of ion energies, the distribution having a most probable energy E; filtering the ion beam to remove at least some ions having an energy less than E from the ion beam; and exposing the lignocellulosic material to the filtered ion beam as the lignocellulosic material moves past the filtered ion beam to cause chain scission of the lignocellulosic material, wherein filtering the ion beam comprises directing the ion beam to pass through a metal foil or a hemispherical analyser.
Patent NZ-630086-A (NZ)
Title: A braze alloy layered product
Inventor: SJÖDIN PER
IPC: C23C24/10
Filed: 2013-03-27
Abstract: A method using transient liquid phase diffusion bonding to connect metal plates is disclosed. The method uses a combination of Boron and Silicon within the braze alloy. The particles are less than 250 micro-meters in size and the silicon and boron include less than 10 wt% contaminating oxygen, which allows even melting and reduced corrosion of the braze alloy. The braze alloy is applied to iron or steel plates and heated until the braze alloy melts and fuses the plates.